For other non-seed genes in breast cancer risk modules, a transcriptomic signature of BMP4 signaling exhibited by primary ER+ breast tumor patients was predictive of improved disease outcome or an improved biologic response to the treatment. This evidence concerns the gene BMP4 and breast neoplasm.